Property:Query string
From GxPlex
"Query string" is a predefined property that describes the conditions of the query as a string and is provided by Semantic MediaWiki. This property is pre-deployed (also known as special property) and comes with additional administrative privileges but can be used just like any other user-defined property.
I
[[Reference:+]] [[HasDocument::Document:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020]]
N
[[Reference:+]] [[HasDocument::Document:N.A. (STROBE)statement: guidelines for reporting observational studies Apr-2008]]
[[Reference:+]] [[HasDocument::Document:N.A. Article from Mora et al. 2023]]
[[Reference:+]] [[HasDocument::Document:N.A. SPIRIT 2013 - Chan et al. 2013]]
W
[[Reference:+]] [[HasDocument::Document:WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report]]
[[Reference:+]] [[HasDocument::Document:WHO WHO - Guidance for best practices for clinical trials 2024]]
[[Reference:+]] [[HasDocument::Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995]]
[[Reference:+]] [[HasDocument::Document:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005]]
[[Reference:+]] [[HasDocument::Document:WMA Declaration of Helsinki 2024]]
D
[[Reference:+]] [[HasDocument::Document:DEU Deutsches Ärzteblatt 45849]]
E
EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838 +
[[Reference:+]] [[HasDocument::Document:EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838]]
W
[[Reference:+]] [[HasDocument::Document:WHO WHO Good Practices for Clinical Trial Design and Implementation 04-May-2026]]
N
[[Reference:+]] [[HasDocument::Document:N.A. Minimum Criteria for ICH E6 (R3) GCP Investigator Site Personnel Training V3.0]]
[[Reference:+]] [[HasDocument::Document:N.A. Transcelerate GCP mutual recognition programm FAQ 21-May-2025]]
G
[[Reference:+]] [[HasDocument::Document:GBR MHRA GCP Inspection Dossier template V7.0]]
U
[[Reference:+]] [[HasDocument::Document:USA WARNING LETTER - Purolea Cosmetics Lab MARCS-CMS 722591 46114]]
D
DEU Richtlinie zur Bewertung der Qualifikation von Prüfern, Hauptprüfern, Leitern und ärztlichen Mitgliedern von Prüfungsteams durch Ethik-Kommissionen von Arbeitskreis Medizinischer Ethik-Kommissionen in der Bundesrepublik Deutschland e. V. und +
[[Reference:+]] [[HasDocument::Document:DEU Richtlinie zur Bewertung der Qualifikation von Prüfern, Hauptprüfern, Leitern und ärztlichen Mitgliedern von Prüfungsteams durch Ethik-Kommissionen von Arbeitskreis Medizinischer Ethik-Kommissionen in der Bundesrepublik Deutschland e. V. und]]
U
[[Reference:+]] [[HasDocument::Document:USA 21 CFR Part 312 09-Apr-2025]]
C
E
[[Reference:+]] [[HasDocument::Document:EU CHMP Guidelines -]]